This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Understanding when index funds are worth it depends on time horizon and fees. This quick guide outlines key scenarios and considerations.
14,180 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Investors debate timing as IREN plans a bold AI expansion after a major capital raise. This guide breaks down the pla...
Mortgage rates surged to a 3-month high, reshaping the investment landscape. A handful of stocks—mortgage servicers, ...
OKX now lets traders access major US stocks around the clock using cryptocurrency as collateral. The new feature deli...
Juggling a full-time job and a bustling household, one parent stacked eight real estate deals in just two years. This...
A California federal court weighs a landmark supply-chain risk dispute between Anthropic and the Department of War, w...
ARK Invest placed a sizable bet on Circle amid a sell-off triggered by draft Clarity Act provisions. The move sparked...
New data on the gender wage gap show women still earn far less than men, marking a second straight year of ground los...
Choosing where to retire isn’t just about weather. It blends cost, healthcare access, taxes, and lifestyle. This guid...
A major security misconfiguration at Anthropic left internal assets, including notes on an unreleased model and CEO r...
Oil markets swing as traders weigh two possible futures depending on how long a conflict will last. The uncertainty i...
In early 2026, women surpassed men in U.S. nonfarm payrolls, signaling a structural shift. This story explores the st...